Aurora: Investor Presentation
High-Margin Strategy
A Sustainable Long-term Business Model
Maximizing average selling
price through:
Leadership in key international markets
allowing strategic focus on highest
margin options (medical, new products)
Full margin capture in international
markets through direct ownership of
distribution channels
Commitment to science and product
development > developing new higher
margin products and marketable IP
Driving down overall production
per gram cash costs through:
Commitment to science and
technology > increasing yields
through genetics, low per gram
operating costs from world-class
automation and replicable large-
scale pharma-style production
Low-input cost locations
Leveraging massive scale to spread
costs over a large volume of product
Production costs
at scale are well
below $1
per gram
AURORA 15View entire presentation